SOPHiA GENETICS SA
SOPH
$7.50
-$0.12-1.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.31M | 21.69M | 21.71M | 19.46M | 18.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.31M | 21.69M | 21.71M | 19.46M | 18.32M |
| Cost of Revenue | 8.25M | 6.94M | 7.02M | 6.56M | 6.05M |
| Gross Profit | 15.06M | 14.75M | 14.69M | 12.91M | 12.27M |
| SG&A Expenses | 26.39M | 22.57M | 24.65M | 22.56M | 22.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.00K | -- | 45.00K | 143.00K | -66.00K |
| Total Operating Expenses | 43.36M | 38.97M | 40.25M | 37.32M | 36.82M |
| Operating Income | -20.05M | -17.28M | -18.54M | -17.86M | -18.49M |
| Income Before Tax | -22.28M | -19.07M | -19.57M | -19.38M | -21.65M |
| Income Tax Expenses | 78.00K | 253.00K | -395.00K | 642.00K | 762.00K |
| Earnings from Continuing Operations | -22.36M | -19.32M | -19.18M | -20.02M | -22.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.36M | -19.32M | -19.18M | -20.02M | -22.41M |
| EBIT | -20.05M | -17.28M | -18.54M | -17.86M | -18.49M |
| EBITDA | -18.90M | -16.13M | -18.10M | -16.77M | -17.48M |
| EPS Basic | -0.30 | -0.27 | -0.28 | -0.30 | -0.33 |
| Normalized Basic EPS | -0.19 | -0.17 | -0.18 | -0.18 | -0.20 |
| EPS Diluted | -0.30 | -0.27 | -0.28 | -0.30 | -0.33 |
| Normalized Diluted EPS | -0.19 | -0.17 | -0.18 | -0.18 | -0.20 |
| Average Basic Shares Outstanding | 73.84M | 71.14M | 68.50M | 67.79M | 67.32M |
| Average Diluted Shares Outstanding | 73.84M | 71.14M | 68.50M | 67.79M | 67.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |